SeekingAlpha · May 15, 2026
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call May 15, 2026 12:00 PM EDTCompany ParticipantsAdam Levy - CEO, President & DirectorIan Blackman - Chief...
NX
NASDAQ · NXGLW
NEXGEL, Inc.
Healthcare · Medical - Instruments & Supplies
$0.01
Down-$0.00 (-9.40%)
Updated Sep 11, 2026, 5:39 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 15.28M
- P/E ratio
- -4.77
- Dividend yield
- 0.00%
- 52-week range
- $0.01 – $0.13
- Volume
- 532
- Avg. volume
- 10.42K
Price performance
NXGLW price history
1M range · 12 trading sessions · Daily adjusted prices
NXGLW closed at $0.01 after 12 trading sessions, down 6.29% for the selected period.
- Last close
- $0.01
- Period change
- -6.29%
- Period low
- $0.01
- Period high
- $0.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $0.015 | $0.015 | $0.0137 | $0.0149 | 532 |
| Sep 4, 2026 | $0.0158 | $0.0159 | $0.0125 | $0.0125 | 9.18K |
| Sep 2, 2026 | $0.0123 | $0.0123 | $0.0123 | $0.0123 | 19.86K |
| Sep 1, 2026 | $0.0121 | $0.0159 | $0.0121 | $0.0159 | 4.44K |
| Aug 26, 2026 | $0.0182 | $0.0182 | $0.0121 | $0.018 | 7.03K |
| Aug 25, 2026 | $0.0181 | $0.0182 | $0.0132 | $0.0169 | 4.16K |
| Aug 21, 2026 | $0.0114 | $0.0114 | $0.0114 | $0.0114 | 14.82K |
| Aug 19, 2026 | $0.0183 | $0.0236 | $0.0116 | $0.0236 | 9.21K |
| Aug 18, 2026 | $0.0179 | $0.0243 | $0.0179 | $0.0199 | 1.58K |
| Aug 17, 2026 | $0.0243 | $0.0243 | $0.0243 | $0.0243 | 1.03K |
| Aug 14, 2026 | $0.0161 | $0.0161 | $0.0113 | $0.0115 | 22.26K |
| Aug 13, 2026 | $0.0164 | $0.0212 | $0.0156 | $0.0159 | 6.01K |
Latest NXGLW news
The latest Smart Investors Daily articles mentioning NXGLW.
Stock researchCompany · Overview
NXGLW research
Overview
Company profile and research snapshot.
Company profile
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Apr 21, 2026
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call April 21, 2026 4:30 PM EDTCompany ParticipantsAdam Levy - CEO, President & DirectorConference Call...
defenseworld.net · Nov 29, 2025
NEXGEL (NASDAQ:NXGLW) Shares Up 18.3% – Time to Buy?
NEXGEL, Inc. (NASDAQ: NXGLW - Get Free Report)'s stock price was up 18.3% on Friday. The company traded as high as $0.22 and last traded at $0.2011. Approximately 15,600 shares changed hands during trading, an increase of 51% from the average daily volume of 10,331 shares. The stock had previously closed at $0.17. NEXGEL Trading
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
